Brief: HCW Biologics Enters Crada With National Cancer Institute
08/12/2022 13:46
Dec 8 (Reuters) - HCW Biologics Inc HCWB.O :
* HCW BIOLOGICS ENTERS CRADA WITH NATIONAL CANCER INSTITUTE
* HCW BIOLOGICS-UNDER CRADA, NCI,CO TO PERFORM PHASE 1B/2
CLINICAL
STUDY TO EVALUATE SAFETY, TOLERABILITY OF, HCW9218
Source text for Eikon: ID:nGNXblBpHQ
Further company coverage: HCWB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hcw Biologics
See all newsBrief: Hcw Biologics Maintains Momentum Toward Completion Of Ind Application For Clinical Study To Evaluate Lead T-Cell Engager In Solid Tumors
Brief: HCW Biologics Registers Resale Of Up To 1.81 Mln Shares Of Common Stock By Selling Stockholder- SEC Filing
NASDAQ RESUMED AT 10:34 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:29 AM
NASDAQ RESUMED AT 10:29 AM